CEP290 and Leber congenital amaurosis: QR-110 treatment increased CEP290 wild-type (26-27) levels in both homozygous and compound heterozygous LCA cells in a dose-dependent manner (Figure 1A), with simultaneous reduction in exon X-containing transcripts (X-27) (Figure 1B).